Rezultati - Per Flodgren
- Showing 1 - 2 results of 2
-
1
-
2
Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma od Bernard Escudier, Jan Roigas, Silke Gillessen, Ulrika Harmenberg, Sandhya Srinivas, Sasja F. Mulder, George Fountzilas, Christian Peschel, Per Flodgren, Edna Chow Maneval, Isan Chen, Nicholas J. Vogelzang
Izdano 2009Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Adverse effect
Cancer
Cancer registry
Confidence interval
Demography
Dosing
Gastroenterology
Gynecology
Incidence (geometry)
Linguistics
Norwegian
Optics
Pediatrics
Philosophy
Physics
Regimen
Relative risk
Renal cell carcinoma
Sociology
Sunitinib
Surgery
Testicular cancer
Tolerability